These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 32139245

  • 1. Clinical update: The important role of dual kidney function testing (ACR and eGFR) in primary care: Identification of risk and management in type 2 diabetes.
    Seidu S, Barrat J, Khunti K.
    Prim Care Diabetes; 2020 Aug; 14(4):370-375. PubMed ID: 32139245
    [Abstract] [Full Text] [Related]

  • 2. Albuminuria and reduced glomerular filtration rate for predicting the renal outcomes in type 2 diabetic patients.
    Tanaka N, Babazono T, Takagi M, Yoshida N, Toya K, Nyumura I, Hanai K, Uchigata Y.
    Nephrology (Carlton); 2015 Aug; 20(8):531-8. PubMed ID: 25773273
    [Abstract] [Full Text] [Related]

  • 3. Markers of early progressive renal decline in type 2 diabetes suggest different implications for etiological studies and prognostic tests development.
    Nowak N, Skupien J, Smiles AM, Yamanouchi M, Niewczas MA, Galecki AT, Duffin KL, Breyer MD, Pullen N, Bonventre JV, Krolewski AS.
    Kidney Int; 2018 May; 93(5):1198-1206. PubMed ID: 29398132
    [Abstract] [Full Text] [Related]

  • 4. Improved clinical trial enrollment criterion to identify patients with diabetes at risk of end-stage renal disease.
    Yamanouchi M, Skupien J, Niewczas MA, Smiles AM, Doria A, Stanton RC, Galecki AT, Duffin KL, Pullen N, Breyer MD, Bonventre JV, Warram JH, Krolewski AS.
    Kidney Int; 2017 Jul; 92(1):258-266. PubMed ID: 28396115
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of albuminuria and glomerular filtration rate on renal and cardiovascular events, and all-cause mortality in Japanese patients with type 2 diabetes.
    Wada T, Haneda M, Furuichi K, Babazono T, Yokoyama H, Iseki K, Araki S, Ninomiya T, Hara S, Suzuki Y, Iwano M, Kusano E, Moriya T, Satoh H, Nakamura H, Shimizu M, Toyama T, Hara A, Makino H, Research Group of Diabetic Nephropathy, Ministry of Health, Labour, and Welfare of Japan.
    Clin Exp Nephrol; 2014 Aug; 18(4):613-20. PubMed ID: 24132561
    [Abstract] [Full Text] [Related]

  • 6. Ethnic disparity in prevalence of diabetic kidney disease in an Asian primary healthcare cluster.
    Loh PT, Toh MP, Molina JA, Vathsala A.
    Nephrology (Carlton); 2015 Mar; 20(3):216-23. PubMed ID: 25495003
    [Abstract] [Full Text] [Related]

  • 7. Plasma Leucine-Rich α-2-Glycoprotein 1 Predicts Rapid eGFR Decline and Albuminuria Progression in Type 2 Diabetes Mellitus.
    Liu JJ, Pek SLT, Ang K, Tavintharan S, Lim SC, SMART2D study.
    J Clin Endocrinol Metab; 2017 Oct 01; 102(10):3683-3691. PubMed ID: 28973352
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".
    Pugliese G, Penno G, Natali A, Barutta F, Di Paolo S, Reboldi G, Gesualdo L, De Nicola L, Italian Diabetes Society and the Italian Society of Nephrology.
    Nutr Metab Cardiovasc Dis; 2019 Nov 01; 29(11):1127-1150. PubMed ID: 31586514
    [Abstract] [Full Text] [Related]

  • 10. A qualitative study documenting unmet needs in the management of diabetic kidney disease (DKD) in the primary care setting.
    Datar M, Ramakrishnan S, Montgomery E, Coca SG, Vassalotti JA, Goss T.
    BMC Public Health; 2021 May 17; 21(1):930. PubMed ID: 34001084
    [Abstract] [Full Text] [Related]

  • 11. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus.
    Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR, Sharma K.
    Am J Nephrol; 2018 May 17; 47(5):283-291. PubMed ID: 29779026
    [Abstract] [Full Text] [Related]

  • 12. Residual proteinuria and eGFR predict progression of renal impairment within 2 years in type 2 diabetic patients with nephropathy who are receiving optimal treatment with angiotensin receptor blockers.
    Ivory SE, Packham DK, Reutens AT, Wolfe R, Rohde RD, Lewis J, Atkins RC, Collaborative Study Group.
    Nephrology (Carlton); 2013 Jul 17; 18(7):516-24. PubMed ID: 23506627
    [Abstract] [Full Text] [Related]

  • 13. Risk Prediction for Early CKD in Type 2 Diabetes.
    Dunkler D, Gao P, Lee SF, Heinze G, Clase CM, Tobe S, Teo KK, Gerstein H, Mann JF, Oberbauer R, ONTARGET and ORIGIN Investigators.
    Clin J Am Soc Nephrol; 2015 Aug 07; 10(8):1371-9. PubMed ID: 26175542
    [Abstract] [Full Text] [Related]

  • 14. Decline in estimated glomerular filtration rate is associated with risk of end-stage renal disease in type 2 diabetes with macroalbuminuria: an observational study from JDNCS.
    Shimizu M, Furuichi K, Toyama T, Funamoto T, Kitajima S, Hara A, Ogawa D, Koya D, Ikeda K, Koshino Y, Kurokawa Y, Abe H, Mori K, Nakayama M, Konishi Y, Samejima KI, Matsui M, Yamauchi H, Gohda T, Fukami K, Nagata D, Yamazaki H, Yuzawa Y, Suzuki Y, Fujimoto S, Maruyama S, Kato S, Naito T, Yoshimura K, Yokoyama H, Wada T, Research Group of Diabetic Nephropathy, the Ministry of Health, Labour, and Welfare of Japan and Japan Agency for Medical Research and Development.
    Clin Exp Nephrol; 2018 Apr 07; 22(2):377-387. PubMed ID: 28889347
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The Prognosis of Patients With Type 2 Diabetes and Nonalbuminuric Diabetic Kidney Disease Is Not Always Poor: Implication of the Effects of Coexisting Macrovascular Complications (JDDM 54).
    Yokoyama H, Araki SI, Kawai K, Yamazaki K, Shirabe SI, Sugimoto H, Minami M, Miyazawa I, Maegawa H, JDDM Study Group.
    Diabetes Care; 2020 May 07; 43(5):1102-1110. PubMed ID: 32144168
    [Abstract] [Full Text] [Related]

  • 20. Prevalence and risk factors for chronic kidney disease in primary health care in the southern region of New Zealand.
    Lloyd H, Li G, Tomlin A, Tilyard MW, Walker R, Schollum J.
    Nephrology (Carlton); 2019 Mar 07; 24(3):308-315. PubMed ID: 29717528
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.